Pheochromocytoma Malignant: Clinical Trials

6 trials for Pheochromocytoma Malignant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 2 unknown. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Recruiting 1, Unknown 1

Follow Pheochromocytoma Malignant: new trials by email Literature Review of Pheochromocytoma Malignant trials Research Report on Pheochromocytoma Malignant

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the Adrenal Disorders Outpatient Clinic of the Clinical Unit of Endocrinology at the Modena University Hospital (AOU Modena)
Cushing s Syndrome, Cushing Disease
RecruitingAzienda Ospedaliero-Universitaria di Modena20002026-07-092026-11-09
An Experimental Study of Belzutifan Impact on Catecholamine Metabolism
Belzutifan - Pheochromocytoma and Paraganglioma (PPGL), Pheochromocytoma Malignant
Phase 2RecruitingCambridge University Hospitals NHS Foundation Trust122026-04-272026-07-02
The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment
Penpulimab - Pheochromocytoma, Metastatic, Pheochromocytoma Malignant
Phase 2UnknownPeking Union Medical College Hospital52023-04-012023-06-02
Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients
Contrast-enhanced ultrasound(CEUS) - Pheochromocytoma, Metastatic, Ultrasonography
UnknownPeking Union Medical College Hospital202023-03-012023-08-29
The Efficacy and Safety of Temozolomide in Patients With MPPGL
Temozolomide capsule - Pheochromocytoma, Metastatic, Paraganglioma, Malignant
Phase 2CompletedPeking Union Medical College Hospital622019-10-012023-05-15
Abdominal Circumference as a Predictor of Operative Time in Retroperitoneal Adrenalectomy for Pheochromocytoma
Retroperitoneal Adrenalectomy - Pheochromocytoma Malignant
CompletedAsan Medical Center1592017-01-012026-01-14

Narrower conditions

Pheochromocytoma (6)  ·  Neoplasm Metastasis (5)  ·  Paraganglioma (3)  ·  Paraganglioma, Extra-Adrenal (3)  ·  ACTH Syndrome, Ectopic (1)  ·  Addison Disease (1)  ·  Adrenal Cortex Neoplasms (1)  ·  Adrenal Gland Diseases (1)  ·  Adrenal Hyperplasia, Congenital (1)  ·  Adrenal Insufficiency (1)  ·  Adrenocortical Hyperfunction (1)  ·  Adrenoleukodystrophy (1)  ·  Hyperaldosteronism (1)  ·  Myelolipoma (1)  ·  Pituitary ACTH Hypersecretion (1)

Broader conditions

Neoplasms (6)  ·  Neoplasms by Histologic Type (6)  ·  Neoplasms, Germ Cell and Embryonal (6)  ·  Neoplasms, Nerve Tissue (6)  ·  Neuroectodermal Tumors (6)  ·  Neuroendocrine Tumors (6)  ·  Neoplastic Processes (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Paraganglioma (3)  ·  Adrenal Cortex Diseases (1)  ·  Adrenal Gland Neoplasms (1)  ·  Adrenogenital Syndrome (1)  ·  Autoimmune Diseases (1)  ·  Brain Diseases (1)

Interventions

Temozolomide (1)  ·  belzutifan (1)  ·  penpulimab (1)

Sponsors

Peking Union Medical College Hospital (3)  ·  Asan Medical Center (1)  ·  Azienda Ospedaliero-Universitaria di Modena (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)

Countries

China (3)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

Anli Tong (3)  ·  Ruth T Casey, MD PhD (1)

Results publications

PMID 26121453, PMID 27479926, PMID 29138385, PMID 29962874, PMID 31985457, PMID 32266384, PMID 37318239, PMID 38151399